Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics